These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20218009)

  • 1. Confirmation that ethanol potentiates aspirin-induced prolongation of the bleeding time.
    Rosove MH; Harwig SS
    Thromb Res; 1983 Aug; 31(3):525-7. PubMed ID: 20218009
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanol potentiation of aspirin-induced prolongation of the bleeding time.
    Deykin D; Janson P; McMahon L
    N Engl J Med; 1982 Apr; 306(14):852-4. PubMed ID: 7062964
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleeding complications related to aspirin dose.
    Laine L; McQuaid K
    Am J Cardiol; 2005 Oct; 96(7):1035-6. PubMed ID: 16188542
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-platelet agents and surgical delay in elderly patients with hip fractures.
    Purushothaman B
    J Orthop Surg (Hong Kong); 2008 Apr; 16(1):130; author reply 130. PubMed ID: 18453679
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
    Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
    Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
    Einecke D
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495
    [No Abstract]   [Full Text] [Related]  

  • 7. Should anticoagulants be prescribed with Aspirin?
    Simonson W
    Geriatr Nurs; 2019; 40(2):212-213. PubMed ID: 30867092
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonist.
    Cai TQ; Wickham LA; Sitko G; Michener MS; Raubertas R; Handt L; Chintala M; Seiffert D; Forrest M
    Eur J Pharmacol; 2015 Jul; 758():107-14. PubMed ID: 25857224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy and the risk of bleeding.
    Ziegelstein RC; Green A; Sauder M
    Arch Intern Med; 2011 Apr; 171(8):787; reply 787-8. PubMed ID: 21518951
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience.
    Fiore M; James C; Mouton C; Calderon J; Barandon L; Ouattara A; Picard F
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3119-25.e1. PubMed ID: 25212058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin as antiplatelet agent in diabetes: Cons.
    Mannucci PM
    Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel (Plavix): dental considerations of an antiplatelet drug.
    Wynn RL; Bergman SA
    Gen Dent; 2001; 49(6):564-8. PubMed ID: 12024741
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban (Xarelto) plus aspirin for secondary prevention of cardiovascular events.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):196-197. PubMed ID: 30653475
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
    Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
    Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-response of aspirin on platelet function in very elderly patients].
    Feng XR; Liu ML; Liu F; Fan Y; Tian QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):835-840. PubMed ID: 27752166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do you need aspirin therapy? Your risks of heart attack and stroke based upon your current and past medical history must be weighed against the chances of internal bleeding.
    Heart Advis; 2009 Aug; 12(8):6. PubMed ID: 21179657
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet disorders in uraemia before and after haemodialysis under the influence of low dose aspirin.
    Tschugguel W; Blaicher A; Kramer L; Felfernig M; Jüngling G; Kurz M; Gnant M; Zimpfer M
    Thromb Res; 1995 Nov; 80(3):225-33. PubMed ID: 8578549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aspirin in MATCH.
    Bath P
    Lancet; 2004 Nov 6-12; 364(9446):1662; author reply 1662-3. PubMed ID: 15530618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.